[Creative Diagnostics] Antibodies and Antigens for Omicron BA.2, Flu A & B, and RSV Combination Test
작성자
abbabio
작성일자
2022-04-21
조회수
241
Newsletter April, 2022
Antibodies and Antigens for Omicron BA.2, Flu A & B, and RSV Combination Tests
Given the similarity in symptoms between COVID-19 and seasonal flu, international organizations for the prevention and control of infectious diseases recommend enhanced surveillance through multiple testing to monitor COVID-19 and other respiratory diseases simultaneously. Since SARS-CoV-2 cocirculates with other respiratory viruses, using the COVID-19 & Flu & RSV combination test that allows differential diagnosis is critical to implementing effective disease control and clinical treatment. Creative Diagnostics offers a broad range of monoclonal antibodies and native antigens for rapid testing of SARS-CoV-2, influenza A (Flu A), influenza B (Flu B), and respiratory syncytial virus (R SV) infections.
The SARS-CoV-2 spike CHO-K1 cell line has been developed by the stable transfection of the SARS-CoV-2 spike protein plasmid. SARS-CoV-2 spike CHO-K1 cell line provides consistent levels of __expression__ of the SARS-CoV-2 spike protein on the cell surface. Delta, Kappa, and Lambda SARS-CoV-2 Pseudotyped Lentivirus Now Available.
With the demand for vaccine development, Creative Diagnostics has developed two ELISA kits for the qualitative detection of SARS-CoV-2 neutralizing antibodies in serum and plasma. Our competitive assay format measures neutralizing antibodies of the SARS-CoV-2 spike RBD and ACE2 interaction in human plasma and serum.
